It’s all quite brazen and absurd. It’s especially rotten that the FDA seems to be placing the blame for a decade and a half of stuffy noses on the manufacturers of cold products – even though it was the government itself that forced them to use inferior ingredients in the first place.
As a journalist, I cannot say much more than the best available facts suggest, but as has been clear for far too long, the mRNA vaccines were not beneficial and safe on a population-level for young, healthy men — yet the CDC and FDA didn’t care. Hopefully, “pro-vaccine publication[s]” may recognize the harm they helped perpetuate.
The ‘acknowledgement’ clause in the order form – acknowledgement, in effect, that the manufacturers knew neither if the vaccine was safe nor if it was effective, at any rate in the long term – is in addition to the clauses which already provide the manufacturers extremely wide-reaching indemnification in the section on indemnification of the contract proper.
Unredacted: The EU’s Hidden Contract with Pfizer-BioNTech Read More
Here we go again. According to the Mail, “experts” (from Independent SAGE, naturally) have called for everyone to be eligible for another Covid booster amid fears the new “concerning” Pirola Covid variant could overwhelm the NHS.
Pfizer is now claiming that the Moderna patents, which Moderna sought to weaponize against Pfizer/BioNTech, are invalid because the technology and invention of using mRNA for vaccination purposes was first disclosed and reduced to practice in 1990.
In January 2021, in the absence of any human data in pregnancy, the CDC stated on its website that mRNA vaccines were “unlikely to pose a specific risk for people who are pregnant.” Behind the scenes however, Pfizer was scrambling to conduct a clinical trial of its vaccine in pregnant women. By February 2022, Pfizer revealed it still did “not yet have a complete data set.”
In George Orwell’s 1984, characters were told by The Party to “reject the evidence of your eyes and [your] ears.” Now, the CDC isn’t even allowing that evidence to be collected for viewing (and prospective rejecting). It’s a terrible idea for any product, let alone novel mRNA technologies.
CDC Now Refusing New COVID Vaccine Adverse Event Reports in Its V-Safe Program Read More
Califf boasted on social media that he took Paxlovid after contracting covid and said the drug could reduce the risk of “long covid” despite it never being validated by robust trials, leading some to criticise him for being “a billboard for Pfizer.”
FDA Head Admits “Cheerleading” Pfizer’s Drug Paxlovid Read More
McKernan’s results – for the Pfizer product (BNT162b2) – have now been independently verified by a number of internationally recognised laboratories confirming both the presence and levels of DNA contamination across different vials and batches. So, in asking the question ‘Is the result reproducible?’ the answer (for the Pfizer product BNT162b2 at least) is ‘Yes.’ The contamination is real.
The Vax-Gene Files: Have the Regulators Approved a Trojan Horse? Read More
However, although the vaccines are not mentioned as the cause, we literally call out the sudden, unprecedented rise in life insurance claims in the 3rd quarter of 2021 among the healthiest sector of society – working age, white collar Americans with group life insurance policies (i.e. largely Fortune 500 corporate employees). What happened in the white-collar workplace at that time?
Remdesivir may be the most despised drug in American history, earning the nickname Run Death Is Near for its lethal record during COVID. Experts claimed that it would stop COVID; instead, it stopped kidney function, then blasted the liver and other organs. Now this reviled destroyer of kidneys has been approved by the FDA for COVID treatment of kidney patients.
How Did Remdesivir Obtain Approval for Kidney Disease? Read More
With reducing interest in vaccine boosters, it appears the public may solve the vaccine access issue themselves. A free flow of information and genuine informed consent will probably accelerate this. So would a responsible attitude from medical journals and regulatory agencies, if they can emerge from the yoke of their sponsors.
